A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.

OBJECTIVES: HIV-1-specific CD8 T cells are considered to be critical in anti-HIV responses. It is important to quantify these cells and to determine their antigenic targets. Here quantification of interferon (IFN)-gamma secreting, virus-specific cells was achieved with an enzyme linked immuno spot (...

Full description

Bibliographic Details
Main Authors: Larsson, M, Jin, X, Ramratnam, B, Ogg, G, Engelmayer, J, Demoitie, M, Mcmichael, A, Cox, W, Steinman, R, Nixon, D, Bhardwaj, N
Format: Journal article
Language:English
Published: 1999
_version_ 1797098676668071936
author Larsson, M
Jin, X
Ramratnam, B
Ogg, G
Engelmayer, J
Demoitie, M
Mcmichael, A
Cox, W
Steinman, R
Nixon, D
Bhardwaj, N
author_facet Larsson, M
Jin, X
Ramratnam, B
Ogg, G
Engelmayer, J
Demoitie, M
Mcmichael, A
Cox, W
Steinman, R
Nixon, D
Bhardwaj, N
author_sort Larsson, M
collection OXFORD
description OBJECTIVES: HIV-1-specific CD8 T cells are considered to be critical in anti-HIV responses. It is important to quantify these cells and to determine their antigenic targets. Here quantification of interferon (IFN)-gamma secreting, virus-specific cells was achieved with an enzyme linked immuno spot (ELISPOT) assay. METHODS: Peripheral blood mononuclear cells (PBMC) were infected with recombinant vaccinia vectors expressing HIV-1 genes (gag, pol, env or nef) and added to wells precoated with anti-IFN-gamma monoclonal antibodies. Spot forming cells (SFC), i.e. antigen-specific T cells were detected 24 h later by the addition of biotinylated anti-IFN-gamma monoclonal antibodies, followed by avidin-bound biotinylated horseradish peroxidase. RESULTS: In a cohort of 19 patients, of whom 15 were on highly active antiretroviral therapy, 18 had primed T cells directed against one or more HIV-1 antigens (P < 0.0001). Pol-specific T cells routinely dominated the CD8 response with frequencies up to 2000 SFC per 10(6) PBMC. In HLA A*0201-positive patients, the vaccinia vectors detected much higher frequencies of SFC than haplotype-restricted peptides. Elimination of CD8 T cells resulted in > 90% loss of antigen-specific SFC when vaccinia virus was used as a vector. The number of CD8 SFC exceeded the number of memory cells detected in limiting dilution assays by > 1 log10, whereas a correlation was found between the frequency of effector cells detected by both ELISPOT and MHC class I peptide tetramer assays. CONCLUSIONS: Vaccinia virus vectors used in ELISPOT assays are useful for determining the frequency and specificity of CD8 T cells for individual HIV-1 gene products. The dominance of cytolytic T lymphocytes (CTL) recognizing pol proteins suggests that this antigen should be considered in vaccine strategies.
first_indexed 2024-03-07T05:13:00Z
format Journal article
id oxford-uuid:dc37c992-ea9f-44d6-b212-417d381df522
institution University of Oxford
language English
last_indexed 2024-03-07T05:13:00Z
publishDate 1999
record_format dspace
spelling oxford-uuid:dc37c992-ea9f-44d6-b212-417d381df5222022-03-27T09:16:08ZA recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dc37c992-ea9f-44d6-b212-417d381df522EnglishSymplectic Elements at Oxford1999Larsson, MJin, XRamratnam, BOgg, GEngelmayer, JDemoitie, MMcmichael, ACox, WSteinman, RNixon, DBhardwaj, NOBJECTIVES: HIV-1-specific CD8 T cells are considered to be critical in anti-HIV responses. It is important to quantify these cells and to determine their antigenic targets. Here quantification of interferon (IFN)-gamma secreting, virus-specific cells was achieved with an enzyme linked immuno spot (ELISPOT) assay. METHODS: Peripheral blood mononuclear cells (PBMC) were infected with recombinant vaccinia vectors expressing HIV-1 genes (gag, pol, env or nef) and added to wells precoated with anti-IFN-gamma monoclonal antibodies. Spot forming cells (SFC), i.e. antigen-specific T cells were detected 24 h later by the addition of biotinylated anti-IFN-gamma monoclonal antibodies, followed by avidin-bound biotinylated horseradish peroxidase. RESULTS: In a cohort of 19 patients, of whom 15 were on highly active antiretroviral therapy, 18 had primed T cells directed against one or more HIV-1 antigens (P < 0.0001). Pol-specific T cells routinely dominated the CD8 response with frequencies up to 2000 SFC per 10(6) PBMC. In HLA A*0201-positive patients, the vaccinia vectors detected much higher frequencies of SFC than haplotype-restricted peptides. Elimination of CD8 T cells resulted in > 90% loss of antigen-specific SFC when vaccinia virus was used as a vector. The number of CD8 SFC exceeded the number of memory cells detected in limiting dilution assays by > 1 log10, whereas a correlation was found between the frequency of effector cells detected by both ELISPOT and MHC class I peptide tetramer assays. CONCLUSIONS: Vaccinia virus vectors used in ELISPOT assays are useful for determining the frequency and specificity of CD8 T cells for individual HIV-1 gene products. The dominance of cytolytic T lymphocytes (CTL) recognizing pol proteins suggests that this antigen should be considered in vaccine strategies.
spellingShingle Larsson, M
Jin, X
Ramratnam, B
Ogg, G
Engelmayer, J
Demoitie, M
Mcmichael, A
Cox, W
Steinman, R
Nixon, D
Bhardwaj, N
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
title A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
title_full A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
title_fullStr A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
title_full_unstemmed A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
title_short A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
title_sort recombinant vaccinia virus based elispot assay detects high frequencies of pol specific cd8 t cells in hiv 1 positive individuals
work_keys_str_mv AT larssonm arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT jinx arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT ramratnamb arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT oggg arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT engelmayerj arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT demoitiem arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT mcmichaela arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT coxw arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT steinmanr arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT nixond arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT bhardwajn arecombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT larssonm recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT jinx recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT ramratnamb recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT oggg recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT engelmayerj recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT demoitiem recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT mcmichaela recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT coxw recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT steinmanr recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT nixond recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals
AT bhardwajn recombinantvacciniavirusbasedelispotassaydetectshighfrequenciesofpolspecificcd8tcellsinhiv1positiveindividuals